Further investigations revealed that this process was mediated by PI3K/AKT/mTOR pathway, resulting in inhibited tumor growth in nude mice, thereby presenting a potential new avenue for treating HCC [126]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.